Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity (Parenthetical)

v3.21.4
Consolidated Statement of Stockholders' Equity (Parenthetical)
$ in Thousands
12 Months Ended
Oct. 03, 2021
USD ($)
$ / shares
shares
Repurchased shares were cancelled 519,266
Treasury stock using the cost method 35,555
Gross proceeds for exercise of warrants | $ $ 283
Fair market value of warranty liability | $ $ 292
Treasury Stock [Member]  
Repurchased shares were cancelled (519,266) [1]
Treasury stock using the cost method 35,555
Warrant [Member]  
Exercise of warrants for common shares | $ / shares $ 1.50
Gross proceeds for exercise of warrants | $ $ 283
Fair market value of warranty liability | $ $ 9
Independent Board of Directors [Member]  
Restricted common shares issued, shares 100,000
Share-based compensation vesting percentage 20.00%
Share-based compensation vesting period 5 years
Restricted common shares issued, value | $ $ 525,000
Amortized over the vesting period, shares 300,000
Share-based compensation, vested, number of shares 60,000
Share-based Compensation, nonvested, number of shares 240,000
[1] Common shares repurchased in the open market between June 11, 2020 and October 3, 2021. On June 14, 2021, 519,266 of the repurchased shares were cancelled, and as of October 3, 2021, 35,555 shares were held in treasury stock using the cost method.